This protocol is judged by an institutional assessment board, an impartial group that evaluations any clinical trials involving individuals. If a study will involve a Schedule I drug, once the board approves the protocol as ethical, the researchers should submit an application for an investigational new drug (IND) number through the FDA.And Becaus… Read More